PLAY PODCASTS
Hypothermia for Severe TBI, RAS Inhibitors After TAVR, OAC-PPI Therapy and UGIB, and more

Hypothermia for Severe TBI, RAS Inhibitors After TAVR, OAC-PPI Therapy and UGIB, and more

JAMA Editors' Summary · American Medical Association

December 4, 20189m 59s

Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the December 04, 2018 issue